Odonate Therapeutics Inc (ODT) is around the bottom of the Biotechnology industry according to InvestorsObserver. ODT received an overall rating of 33, which means that it scores higher than 33 percent of all stocks. Odonate Therapeutics Inc also achieved a score of 20 in the Biotechnology industry, putting it above 20 percent of Biotechnology stocks. Biotechnology is ranked 25 out of the 148 industries.
What do These Ratings Mean?
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 33 means the stock is more attractive than 33 percent of stocks.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What's Happening With Odonate Therapeutics Inc Stock Today?
Odonate Therapeutics Inc (ODT) stock is trading at $17.65 as of 3:06 PM on Wednesday, Aug 26, a gain of $0.15, or 0.86% from the previous closing price of $17.50. Volume today is more active than usual. So far 551,544 shares have traded compared to average volume of 251,597 shares. The stock has traded between $16.85 and $17.98 so far today.
To see InvestorsObserver's Sentiment Score for Odonate Therapeutics Inc click here.
